Skip to main content
. 2023 Aug 1;53(11):744–755. doi: 10.4070/kcj.2023.0022

Table 1. Baseline characteristics of overall and propensity-score matched population.

Total study population Propensity-score matched population
Early AVR (n=121) Conservative care (n=160) SMD Early AVR (n=121) Conservative care (n=121) SMD
Age (years) 75.1±9.8 77.1±9.7 0.206 75.1±9.8 76.5±10.0 0.141
Female sex 63 (52.1) 105 (65.6) 0.278 63 (52.1) 72 (59.5) 0.150
Body surface area (m2) 1.63±0.18 1.59±0.16 0.241 1.63±0.18 1.61±0.16 0.102
Body mass index (kg/m2) 24.0±3.8 23.5±3.8 0.122 24.0±3.8 23.9±3.7 0.031
Hypertension 74 (61.2) 99 (61.9) 0.015 74 (61.2) 73 (60.3) 0.017
Diabetes on insulin 19 (15.7) 14 (11.6) 0.150 19 (15.7) 14 (11.6) 0.120
Chronic kidney disease 44 (36.4) 63 (39.4) 0.062 44 (36.4) 43 (35.5) 0.017
On dialysis 8 (6.6) 10 (6.2) 0.015 8 (6.6) 7 (5.8) 0.034
Coronary artery disease 14 (11.6) 24 (15.0) 0.101 14 (11.6) 15 (12.4) 0.025
Peripheral artery disease 6 (5.0) 11 (6.9) 0.081 6 (5.0) 7 (5.8) 0.037
Old cerebrovascular accident 3 (2.5) 10 (6.2) 0.185 3 (2.5) 3 (2.5) <0.001
Atrial fibrillation 9 (7.4) 18 (11.2) 0.131 9 (7.4) 11 (9.1) 0.060
Pacemaker implantation 1 (0.8) 3 (1.9) 0.091 1 (0.8) 1 (0.8) <0.001
Chronic lung disease 12 (9.9) 15 (9.4) 0.018 12 (9.9) 11 (9.1) 0.028
Chronic liver disease 3 (2.5) 4 (2.5) 0.001 3 (2.5) 4 (3.3) 0.049
Bicuspid aortic valve 15 (12.4) 15 (9.4) 0.097 15 (12.4) 12 (9.9) 0.079
Symptoms 0.182 0.137
NYHA class I–II 105 (86.8) 128 (80.0) 105 (86.8) 99 (81.8)
NYHA class III–IV 16 (13.2) 32 (20.0) 16 (13.2) 22 (18.2)
Estimated PASP 30.0 (25.0–35.0) 31.0 (26.5–39.0) 0.235 30.0 (25.0–35.0) 31.0 (27.0–36.0) 0.156
EuroSCORE II (%) 1.60 (1.06–2.21) 1.80 (1.34–2.62) 0.286 1.60 (1.06–2.21) 1.79 (1.29–2.39) 0.159

Values are presented as number (%), mean±standard deviation or median (range).

AVR = aortic valve replacement; EuroSCORE = European System for Cardiac Operative Risk Evaluation; NYHA = New York Heart Association, PASP = pulmonary artery systolic pressure; SMD = standardized mean difference.